These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 25531135)
21. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells. Summan M; Cribb AE Chem Biol Interact; 2002 Nov; 142(1-2):155-73. PubMed ID: 12399161 [TBL] [Abstract][Full Text] [Related]
22. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis. Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640 [TBL] [Abstract][Full Text] [Related]
23. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. Depta JP; Altznauer F; Gamerdinger K; Burkhart C; Weltzien HU; Pichler WJ J Allergy Clin Immunol; 2004 Mar; 113(3):519-27. PubMed ID: 15007356 [TBL] [Abstract][Full Text] [Related]
24. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233 [TBL] [Abstract][Full Text] [Related]
25. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives. Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178 [TBL] [Abstract][Full Text] [Related]
26. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Naisbitt DJ; Hough SJ; Gill HJ; Pirmohamed M; Kitteringham NR; Park BK Br J Pharmacol; 1999 Mar; 126(6):1393-407. PubMed ID: 10217534 [TBL] [Abstract][Full Text] [Related]
27. Direct photolysis of human metabolites of the antibiotic sulfamethoxazole: evidence for abiotic back-transformation. Bonvin F; Omlin J; Rutler R; Schweizer WB; Alaimo PJ; Strathmann TJ; McNeill K; Kohn T Environ Sci Technol; 2013 Jul; 47(13):6746-55. PubMed ID: 23186099 [TBL] [Abstract][Full Text] [Related]
28. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. Sanderson JP; Naisbitt DJ; Farrell J; Ashby CA; Tucker MJ; Rieder MJ; Pirmohamed M; Clarke SE; Park BK J Immunol; 2007 May; 178(9):5533-42. PubMed ID: 17442935 [TBL] [Abstract][Full Text] [Related]
29. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. Cribb AE; Miller M; Tesoro A; Spielberg SP Mol Pharmacol; 1990 Nov; 38(5):744-51. PubMed ID: 2172779 [TBL] [Abstract][Full Text] [Related]
30. Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulphonamide hypersensitivity: a naturally occurring model of idiosyncratic drug toxicity. Lavergne SN; Danhof RS; Volkman EM; Trepanier LA Clin Exp Allergy; 2006 Jul; 36(7):907-15. PubMed ID: 16839406 [TBL] [Abstract][Full Text] [Related]
31. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC). Ott G; Plitzko B; Krischkowski C; Reichmann D; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A Chem Res Toxicol; 2014 Oct; 27(10):1687-95. PubMed ID: 25170804 [TBL] [Abstract][Full Text] [Related]
32. Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat. Cribb AE; McQuaid T; Renton KW Biochem Pharmacol; 2001 Aug; 62(4):457-9. PubMed ID: 11448455 [TBL] [Abstract][Full Text] [Related]
33. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso. Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451 [TBL] [Abstract][Full Text] [Related]
34. Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells. Roychowdhury S; Vyas PM; Svensson CK Drug Metab Dispos; 2007 Apr; 35(4):676-81. PubMed ID: 17220235 [TBL] [Abstract][Full Text] [Related]
35. Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism. Cribb AE; Nakamura H; Grant DM; Miller MA; Spielberg SP Biochem Pharmacol; 1993 Mar; 45(6):1277-82. PubMed ID: 8466547 [TBL] [Abstract][Full Text] [Related]
37. Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients. Wang D; Curtis A; Papp AC; Koletar SL; Para MF BMC Med Genomics; 2012 Jul; 5():32. PubMed ID: 22824134 [TBL] [Abstract][Full Text] [Related]
38. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Cribb AE; Spielberg SP; Griffin GP Drug Metab Dispos; 1995 Mar; 23(3):406-14. PubMed ID: 7628308 [TBL] [Abstract][Full Text] [Related]
39. Exogenous cofactors for the improvement of bioremoval and biotransformation of sulfamethoxazole by Alcaligenes faecalis. Zhang YB; Zhou J; Xu QM; Cheng JS; Luo YL; Yuan YJ Sci Total Environ; 2016 Sep; 565():547-556. PubMed ID: 27203516 [TBL] [Abstract][Full Text] [Related]